Depressive, anxiety and hypomanic symptoms in schizophrenia may be driven by tryptophan catabolite (TRYCAT) patterning of IgA and IgM responses directed to TRYCATs

Kanchanatawan, B., Maes, M., & al., e. (). Depressive, anxiety and hypomanic symptoms in schizophrenia may be driven by tryptophan catabolite (TRYCAT) patterning of IgA and IgM responses directed to TRYCATs. Progress in Neuro-Psychopharmacology and Biological Psychiatry; Progress in Neuro-Psychopharmacology and Biological Psychiatry.